40 related articles for article (PubMed ID: 35230875)
21. Antihistamines and azithromycin as a treatment for COVID-19 on primary health care - A retrospective observational study in elderly patients.
Morán Blanco JI; Alvarenga Bonilla JA; Homma S; Suzuki K; Fremont-Smith P; Villar Gómez de Las Heras K
Pulm Pharmacol Ther; 2021 Apr; 67():101989. PubMed ID: 33465426
[TBL] [Abstract][Full Text] [Related]
22. Rationale for azithromycin in COVID-19: an overview of existing evidence.
Gyselinck I; Janssens W; Verhamme P; Vos R
BMJ Open Respir Res; 2021 Jan; 8(1):. PubMed ID: 33441373
[TBL] [Abstract][Full Text] [Related]
23. The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis.
Liu H; Yang D; Chen X; Sun Z; Zou Y; Chen C; Sun S
Cancer Med; 2021 Feb; 10(3):1043-1056. PubMed ID: 33381923
[TBL] [Abstract][Full Text] [Related]
24. Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection.
Wang Q; Berger NA; Xu R
JAMA Oncol; 2021 Feb; 7(2):220-227. PubMed ID: 33300956
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil to lymphocyte ratio and C-reactive protein level as prognostic markers in mild versus severe COVID-19 patients.
Mousavi-Nasab SD; Mardani R; Nasr Azadani H; Zali F; Ahmadi Vasmehjani A; Sabeti S; Alavi Darazam I; Ahmadi N
Gastroenterol Hepatol Bed Bench; 2020; 13(4):361-366. PubMed ID: 33244379
[TBL] [Abstract][Full Text] [Related]
26. Clinical manifestation and disease progression in COVID-19 infection.
Tsai PH; Lai WY; Lin YY; Luo YH; Lin YT; Chen HK; Chen YM; Lai YC; Kuo LC; Chen SD; Chang KJ; Liu CH; Chang SC; Wang FD; Yang YP
J Chin Med Assoc; 2021 Jan; 84(1):3-8. PubMed ID: 33230062
[TBL] [Abstract][Full Text] [Related]
27. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.
; Sterne JAC; Murthy S; Diaz JV; Slutsky AS; Villar J; Angus DC; Annane D; Azevedo LCP; Berwanger O; Cavalcanti AB; Dequin PF; Du B; Emberson J; Fisher D; Giraudeau B; Gordon AC; Granholm A; Green C; Haynes R; Heming N; Higgins JPT; Horby P; Jüni P; Landray MJ; Le Gouge A; Leclerc M; Lim WS; Machado FR; McArthur C; Meziani F; Møller MH; Perner A; Petersen MW; Savovic J; Tomazini B; Veiga VC; Webb S; Marshall JC
JAMA; 2020 Oct; 324(13):1330-1341. PubMed ID: 32876694
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy and COVID-19 Outcomes in Patients With Cancer.
Jee J; Foote MB; Lumish M; Stonestrom AJ; Wills B; Narendra V; Avutu V; Murciano-Goroff YR; Chan JE; Derkach A; Philip J; Belenkaya R; Kerpelev M; Maloy M; Watson A; Fong C; Janjigian Y; Diaz LA; Bolton KL; Pessin MS
J Clin Oncol; 2020 Oct; 38(30):3538-3546. PubMed ID: 32795225
[TBL] [Abstract][Full Text] [Related]
29. Dexamethasone in Hospitalized Patients with Covid-19.
; Horby P; Lim WS; Emberson JR; Mafham M; Bell JL; Linsell L; Staplin N; Brightling C; Ustianowski A; Elmahi E; Prudon B; Green C; Felton T; Chadwick D; Rege K; Fegan C; Chappell LC; Faust SN; Jaki T; Jeffery K; Montgomery A; Rowan K; Juszczak E; Baillie JK; Haynes R; Landray MJ
N Engl J Med; 2021 Feb; 384(8):693-704. PubMed ID: 32678530
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from Wuhan, China.
Zhang H; Wang L; Chen Y; Wu Q; Chen G; Shen X; Wang Q; Yan Y; Yu Y; Zhong Y; Wang X; Chua MLK; Xie C
Cancer; 2020 Sep; 126(17):4023-4031. PubMed ID: 32573776
[TBL] [Abstract][Full Text] [Related]
31. Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?
Karampela I; Dalamaga M
Arch Med Res; 2020 Oct; 51(7):741-742. PubMed ID: 32546446
[TBL] [Abstract][Full Text] [Related]
32. Cytokine storm induced by SARS-CoV-2.
Song P; Li W; Xie J; Hou Y; You C
Clin Chim Acta; 2020 Oct; 509():280-287. PubMed ID: 32531256
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and outcomes of cancer patients with COVID-19.
Yang F; Shi S; Zhu J; Shi J; Dai K; Chen X
J Med Virol; 2020 Oct; 92(10):2067-2073. PubMed ID: 32369209
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data.
Martins-Filho PR; Tavares CSS; Santos VS
Eur J Intern Med; 2020 Jun; 76():97-99. PubMed ID: 32345526
[No Abstract] [Full Text] [Related]
35. Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome.
Arabi YM; Mandourah Y; Al-Hameed F; Sindi AA; Almekhlafi GA; Hussein MA; Jose J; Pinto R; Al-Omari A; Kharaba A; Almotairi A; Al Khatib K; Alraddadi B; Shalhoub S; Abdulmomen A; Qushmaq I; Mady A; Solaiman O; Al-Aithan AM; Al-Raddadi R; Ragab A; Balkhy HH; Al Harthy A; Deeb AM; Al Mutairi H; Al-Dawood A; Merson L; Hayden FG; Fowler RA;
Am J Respir Crit Care Med; 2018 Mar; 197(6):757-767. PubMed ID: 29161116
[TBL] [Abstract][Full Text] [Related]
36. The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study.
Auyeung TW; Lee JS; Lai WK; Choi CH; Lee HK; Lee JS; Li PC; Lok KH; Ng YY; Wong WM; Yeung YM
J Infect; 2005 Aug; 51(2):98-102. PubMed ID: 16038758
[TBL] [Abstract][Full Text] [Related]
37. Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients.
Lee N; Allen Chan KC; Hui DS; Ng EK; Wu A; Chiu RW; Wong VW; Chan PK; Wong KT; Wong E; Cockram CS; Tam JS; Sung JJ; Lo YM
J Clin Virol; 2004 Dec; 31(4):304-9. PubMed ID: 15494274
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
[TBL] [Abstract][Full Text] [Related]
39. COVID-19 Disease in Syrian Patients With Cancer: Clinical Manifestations, Laboratory Findings, Treatment, and Outcomes.
Najjar M; Albuaini S; Fadel M; Aljbawi A; Mohsen F; Sulaiman S; Koudsi A
JCO Glob Oncol; 2022 Mar; 8():e2100283. PubMed ID: 35230875
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
